Measles Encephalitis: Towards New Therapeutics

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2019 Nov 6

PMID 31684034

Citations 37

Authors

Marion Ferren

Branka Horvat

Cyrille Mathieu

Affiliations

Soon will be listed here.

Abstract

Measles remains a major cause of morbidity and mortality worldwide among vaccine preventable diseases. Recent decline in vaccination coverage resulted in re-emergence of measles outbreaks. Measles virus (MeV) infection causes an acute systemic disease, associated in certain cases with central nervous system (CNS) infection leading to lethal neurological disease. Early following MeV infection some patients develop acute post-infectious measles encephalitis (APME), which is not associated with direct infection of the brain. MeV can also infect the CNS and cause sub-acute sclerosing panencephalitis (SSPE) in immunocompetent people or measles inclusion-body encephalitis (MIBE) in immunocompromised patients. To date, cellular and molecular mechanisms governing CNS invasion are still poorly understood. Moreover, the known MeV entry receptors are not expressed in the CNS and how MeV enters and spreads in the brain is not fully understood. Different antiviral treatments have been tested and validated in vitro, ex vivo and in vivo mainly in small animal models. Most treatments have high efficacy at preventing infection but their effectiveness after CNS manifestations remains to be evaluated. This review describes MeV neural infection and current most advanced therapeutic approaches potentially applicable to treat MeV CNS infection.

Citing Articles

Subacute Sclerosing Panencephalitis: Impact on Public Health, Current Insights, and Future Perspectives.

Mubbashir Z, Tharwani Z, Kambar T, Munawar S, Raphael O, Siddiqui I Brain Behav. 2025; 15(2):e70292.

PMID: 39924947 PMC: 11808179. DOI: 10.1002/brb3.70292.

Identifying and reducing risks of neurological complications associated with vaccination.

Handunnetthi L, Ramasamy M, Turtle L, Hunt D Nat Rev Neurol. 2024; 20(9):541-554.

PMID: 39112653 DOI: 10.1038/s41582-024-01000-7.

A Rare Case of Subacute Sclerosing Panencephalitis in an Immunized Patient.

Shaligram R, Garud B, Jadhav R, Chalipat S, Mane S Cureus. 2024; 16(6):e63258.

PMID: 39070335 PMC: 11282383. DOI: 10.7759/cureus.63258.

Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases.

Nurmukanova V, Matsvay A, Gordukova M, Shipulin G Viruses. 2024; 16(5).

PMID: 38793668 PMC: 11126052. DOI: 10.3390/v16050787.

Helical peptides with disordered regions for measles viruses provide new generalized insights into fusion inhibitors.

Hirata K, Takahara A, Suzuki S, Murakami S, Kawaji K, Nishiyama A iScience. 2024; 27(2):108961.

PMID: 38333694 PMC: 10850769. DOI: 10.1016/j.isci.2024.108961.

References

Moeller K, Duffy I, Duprex P, Rima B, Beschorner R, Fauser S . Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence. J Virol. 2001; 75(16):7612-20. PMC: 114996. DOI: 10.1128/JVI.75.16.7612-7620.2001. View

Iwasaki M, Takeda M, Shirogane Y, Nakatsu Y, Nakamura T, Yanagi Y . The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol. 2009; 83(20):10374-83. PMC: 2753126. DOI: 10.1128/JVI.01056-09. View

Ader N, Brindley M, Avila M, Orvell C, Horvat B, Hiltensperger G . Mechanism for active membrane fusion triggering by morbillivirus attachment protein. J Virol. 2012; 87(1):314-26. PMC: 3536382. DOI: 10.1128/JVI.01826-12. View

Garg R . Acute disseminated encephalomyelitis. Postgrad Med J. 2003; 79(927):11-7. PMC: 1742586. DOI: 10.1136/pmj.79.927.11. View

Patterson J, Cornu T, Redwine J, Dales S, Lewicki H, Holz A . Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology. 2002; 291(2):215-25. DOI: 10.1006/viro.2001.1182. View

Reuter D, Schneider-Schaulies J . Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol. 2010; 199(3):261-71. DOI: 10.1007/s00430-010-0153-2. View

Rall G, Manchester M, DANIELS L, Callahan E, Belman A, Oldstone M . A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A. 1997; 94(9):4659-63. PMC: 20780. DOI: 10.1073/pnas.94.9.4659. View

Prashanth L, Taly A, Ravi V, Sinha S, Rao S . Long term survival in subacute sclerosing panencephalitis: an enigma. Brain Dev. 2006; 28(7):447-52. DOI: 10.1016/j.braindev.2006.01.008. View

Budaszewski R, von Messling V . Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus. Viruses. 2016; 8(10). PMC: 5086610. DOI: 10.3390/v8100274. View

10.

Semba R, Bloem M . Measles blindness. Surv Ophthalmol. 2004; 49(2):243-55. DOI: 10.1016/j.survophthal.2003.12.005. View

11.

Miller C, Andrews N, Rush M, Munro H, Jin L, Miller E . The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child. 2004; 89(12):1145-8. PMC: 1719740. DOI: 10.1136/adc.2003.038489. View

12.

Hughes I, Jenney M, Newton R, Morris D, Klapper P . Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1993; 68(6):775-8. PMC: 1029373. DOI: 10.1136/adc.68.6.775. View

13.

Choi Y, Simon M, Yoon B, Kwon S, Lee K, Seo I . Fatal measles virus infection in Japanese macaques (Macaca fuscata). Vet Pathol. 1999; 36(6):594-600. DOI: 10.1354/vp.36-6-594. View

14.

Brechot C, Bryant J, Endtz H, Garry R, Griffin D, Lewin S . 2018 international meeting of the Global Virus Network. Antiviral Res. 2019; 163:140-148. PMC: 7127431. DOI: 10.1016/j.antiviral.2019.01.013. View

15.

McQuaid S, Campbell S, Wallace I, Kirk J, Cosby S . Measles virus infection and replication in undifferentiated and differentiated human neuronal cells in culture. J Virol. 1998; 72(6):5245-50. PMC: 110109. DOI: 10.1128/JVI.72.6.5245-5250.1998. View

16.

Moeller-Ehrlich K, Ludlow M, Beschorner R, Meyermann R, Rima B, Duprex W . Two functionally linked amino acids in the stem 2 region of measles virus haemagglutinin determine infectivity and virulence in the rodent central nervous system. J Gen Virol. 2007; 88(Pt 11):3112-3120. DOI: 10.1099/vir.0.83235-0. View

17.

Ben-Chetrit E, Oster Y, Jarjoui A, Megged O, Lachish T, Cohen M . Measles-related hospitalizations and associated complications in Jerusalem, 2018-2019. Clin Microbiol Infect. 2019; 26(5):637-642. DOI: 10.1016/j.cmi.2019.08.022. View

18.

Tatsuo H, Ono N, Tanaka K, Yanagi Y . SLAM (CDw150) is a cellular receptor for measles virus. Nature. 2000; 406(6798):893-7. DOI: 10.1038/35022579. View

19.

Bellini W, Rota J, Lowe L, Katz R, Dyken P, Zaki S . Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis. 2005; 192(10):1686-93. DOI: 10.1086/497169. View

20.

Plattet P, Alves L, Herren M, Aguilar H . Measles Virus Fusion Protein: Structure, Function and Inhibition. Viruses. 2016; 8(4):112. PMC: 4848605. DOI: 10.3390/v8040112. View